September 26, 2023 – An estimated 18 million adults within the U.S. have had Long COVID, and half of them are still battling the disease, recent national survey data shows.
CDC findings National Health Interview Survey in 2022 found that 6.9% of adults self-reported having COVID symptoms for not less than three months after testing positive or being diagnosed with COVID-19 by a health care provider.
The estimate is significantly lower previous CDC survey data shows that roughly 14 to fifteen percent of adults within the United States have Long COVID.
The CDC also recently reported that 1.3% of US children had long-COVID disease and 0.5% of youngsters had symptoms lasting not less than three months on the time of the survey in 2022.
The agency lists 19 possible long-COVID Symptomsincluding tiredness, shortness of breath, palpitations, difficulty concentrating and changes within the sense of smell or taste, in addition to worsening of symptoms with physical or mental exertion.
The 2022 survey results were analyzed using demographic aspects comparable to income, gender, age, and race or ethnicity to find out whether groups of persons are affected otherwise by Long COVID.
Wealthy people were the least more likely to report having long COVID, while people whose family income was well below the federal poverty line were the most probably to have long COVID. Women were more likely than men to have ever had long COVID or to currently have the disease. People aged 35 to 49 were the most probably to report having the disease.
When researchers checked out how long COVID affected people by race or ethnicity, the information showed:
- 8.3% of Hispanics reported having had long-COVID-19 before, and three.4% are currently affected.
- 7.1% of whites reported having had Long COVID before, and three.7% are currently affected.
- 5.4% of blacks reported having had long-COVID-19 before, and a pair of.4% are currently affected.
- 2.6 percent of Asians reported having had Long COVID before, and 1.1 percent are currently affected.
Last summer, the US Department of Health announced the introduction of a government-funded clinical trials to research the symptoms, treatments and prevention of Long-COVID-19.